[
  {
    "ts": null,
    "headline": "Why Nike (NKE) Is Among the Best Retail Stocks to Buy Right Now",
    "summary": "We recently published a list of 11 Best Retail Stocks to Buy Right Now. In this article, we are going to take a look at where Nike, Inc. (NYSE:NKE) stands against other best retail stocks to buy right now. Resilient Consumer Spending, Falling Consumer Sentiment Although the stock market is undergoing volatility due to the […]",
    "url": "https://finnhub.io/api/news?id=1d6bfab2ca4b4d84cd92f66fefe6bb1844cf6af68e09472c0b3e5e424e6511fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745091083,
      "headline": "Why Nike (NKE) Is Among the Best Retail Stocks to Buy Right Now",
      "id": 134023009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "NKE",
      "source": "Yahoo",
      "summary": "We recently published a list of 11 Best Retail Stocks to Buy Right Now. In this article, we are going to take a look at where Nike, Inc. (NYSE:NKE) stands against other best retail stocks to buy right now. Resilient Consumer Spending, Falling Consumer Sentiment Although the stock market is undergoing volatility due to the […]",
      "url": "https://finnhub.io/api/news?id=1d6bfab2ca4b4d84cd92f66fefe6bb1844cf6af68e09472c0b3e5e424e6511fd"
    }
  },
  {
    "ts": null,
    "headline": "3 Magnificent Stocks to Buy That Are Near 52-Week Lows",
    "summary": "It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration.  Zoetis (NYSE: ZTS) is a global leader in animal health, with an extensive portfolio of medicines, vaccines, and diagnostic products for livestock and pets.  The company's diversification, covering 17 products generating over $100 million in annual revenue, including several best-in-class treatments, underscores its appeal as an investment.",
    "url": "https://finnhub.io/api/news?id=1e4e9d0c44a3b9b308482597b3051652778f7689f6e3eeb8fb6a5d1f45d77fe5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745065800,
      "headline": "3 Magnificent Stocks to Buy That Are Near 52-Week Lows",
      "id": 134022912,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "NKE",
      "source": "Yahoo",
      "summary": "It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration.  Zoetis (NYSE: ZTS) is a global leader in animal health, with an extensive portfolio of medicines, vaccines, and diagnostic products for livestock and pets.  The company's diversification, covering 17 products generating over $100 million in annual revenue, including several best-in-class treatments, underscores its appeal as an investment.",
      "url": "https://finnhub.io/api/news?id=1e4e9d0c44a3b9b308482597b3051652778f7689f6e3eeb8fb6a5d1f45d77fe5"
    }
  },
  {
    "ts": null,
    "headline": "Why Nike's Bruised Stock Might Be A Long-Term Winner",
    "summary": "Why Nike's Bruised Stock Might Be A Long-Term Winner",
    "url": "https://finnhub.io/api/news?id=7efb974ba94ea7eb4001e6a4eb2f724a4114ce52a3b5a57c21a9401278cc7326",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745027242,
      "headline": "Why Nike's Bruised Stock Might Be A Long-Term Winner",
      "id": 133968854,
      "image": "",
      "related": "NKE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7efb974ba94ea7eb4001e6a4eb2f724a4114ce52a3b5a57c21a9401278cc7326"
    }
  }
]